P
EBS icon

Pitcairn’s Emergent Biosolutions EBS Stock Holding History

Pitcairn’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,612
Closed -$522K – 617
2021
Q1 		$522K Buy
5,612
+1,135
+25% +$116K 0.04% 316
2020
Q4 		$401K Sell
4,477
-46
-1% -$4.22K 0.03% 354
2020
Q3 		$467K Sell
4,523
-567
-11% -$61.1K 0.04% 263
2020
Q2 		$402K Buy
5,090
+471
+10% +$35.1K 0.04% 271
2020
Q1 		$268K Buy
4,619
+309
+7% +$17.8K 0.03% 323
2019
Q4 		$233K Sell
4,310
-7,351
-63% -$399K 0.02% 481
2019
Q3 		$610K Buy
11,661
+419
+4% +$19.5K 0.06% 206
2019
Q2 		$543K Sell
11,242
-915
-8% -$43.9K 0.05% 228
2019
Q1 		$614K Buy
12,157
+5,106
+72% +$301K 0.07% 188
2018
Q4 		$418K Buy
7,051
+266
+4% +$17.1K 0.05% 221
2018
Q3 		$446K Buy
6,785
+873
+15% +$50.9K 0.05% 284
2018
Q2 		$298K Buy
5,912
+98
+2% +$5.11K 0.03% 398
2018
Q1 		$306K Buy
+5,814
New +$290K 0.03% 377
2016
Q2 		– Sell
-7,036
Closed -$255K – 462
2016
Q1 		$255K Buy
7,036
+893
+15% +$31.5K 0.03% 382
2015
Q4 		$246K Buy
+6,143
New +$214K 0.03% 382
2015
Q3 		– Sell
-7,078
Closed -$233K – 430
2015
Q2 		$233K Sell
7,078
-495
-7% -$15.3K 0.03% 415
2015
Q1 		$218K Buy
7,573
+219
+3% +$6.28K 0.02% 449
2014
Q4 		$200K Buy
+7,354
New +$175K 0.02% 465

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pitcairn's EBS Position: Q2 2021 in Review

Pitcairn sold out of Emergent Biosolutions (EBS) in Q2 2021, closing a stake of 5,612 shares — an estimated $522K sold.

Pitcairn first reported a position in EBS in Q4 2014 and held it in 18 quarters. The position peaked at $614K in Q1 2019. 290 funds tracked by Wall St. Rank hold EBS as of Q2 2021.

  • Pitcairn reported no remaining Emergent Biosolutions position as of Q2 2021 after selling out during the quarter.
  • Pitcairn sold 5,612 Emergent Biosolutions shares in Q2 2021, an estimated $522K.
  • Pitcairn first reported a position in Emergent Biosolutions in Q4 2014 and held it in 18 quarters.
  • Pitcairn's Emergent Biosolutions position peaked at $614K in Q1 2019.
  • 290 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2021.

Based on Pitcairn's 13F filing for Q2 2021, filed 11 Aug 2021.